Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10428054 | 0.87 | MEN1 (0.35) | MEN1KMT2ATDP1 | |
| SCHEMBL11643851 | 0.81 | MEN1 (0.32) | MEN1KMT2ATDP1 | |
| SCHEMBL1524186 | 0.81 | MEN1 (0.35) | MEN1KMT2ATDP1 | |
| SCHEMBL8193798 | 0.79 | — | — | |
| SCHEMBL18496394 | 0.78 | MEN1 (0.38) | MEN1KMT2ATDP1 | |
| SCHEMBL8402370 | 0.75 | MEN1 (0.44) | MEN1KMT2ATDP1 | |
| SCHEMBL11612420 | 0.75 | MEN1 (0.44) | MEN1KMT2ATDP1 | |
| SCHEMBL1279924 | 0.75 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL666417 | 0.73 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL890624 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697389-B2 | Cell labeling and imaging using multifunctional perfluorocarbon nanoemulsion | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-04-15 | — | — | US | claimed |
| US-20120088261-A1 | CELL LABELING AND IMAGING USING MULTIFUNCTIONAL PERFLUOROCARBON NANOEMULSION | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2012-04-12 | — | — | US | claimed |
| US-5989918-A | DETERMINING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION AND PHARMACOKINETICS OF TEST COMPOUND IN ISOLATED LIVE ORGAN USING FLUOROCARBON EMULSION AS BLOOD SUBSTITUTE, ADDING COMPOUND, DISRUPTING EMULSION OF SAMPLE, ANALYSIS | CHIRON CORPORATION (US) | 1999-11-23 | — | — | US | claimed |
| EP-0923733-A1 | METHOD FOR ANALYSING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION (ADME) AND PHARMACOKINETICS PROPERTIES OF COMPOUND MIXTURES | CHIRON CORPORATION (US) | 1999-06-23 | — | — | EP | claimed |
| WO-1998009166-A1 | METHOD FOR ANALYSING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION (ADME) AND PHARMACOKINETICS PROPERTIES OF COMPOUND MIXTURES | CHIRON CORPORATION (US) | 1998-03-05 | — | — | WO | claimed |
| EP-0558423-B1 | Cosmetic or dermatologic composition in the form of a dispersion of an organofluorinated hydrocarbon in an aqueous solution of a hydrosoluble film-forming polymer, capable of forming composite films | OREAL (FR) | 1996-05-22 | — | — | EP | claimed |
| US-5518731-A | Nonaqueous fluorinated drug delivery vehicle suspensions | ALLERGAN, INC. (US) | 1996-05-21 | — | — | US | claimed |
| EP-0606308-A1 | FLUOROALKYLATED AMPHIPHILIC LIGANDS, THEIR METALLIC COMPLEXES AND THEIR USES | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-07-20 | — | — | EP | claimed |
| EP-0274431-B1 | Drug delivery compositions and methods | QUIXOTE CORP (US) | 1994-05-04 | — | — | EP | claimed |
| WO-1993007123-A1 | FLUOROALKYLATED AMPHIPHILIC LIGANDS, THEIR METALLIC COMPLEXES AND THEIR USES | S.A. A.T.T.A. APPLICATIONS ET TRANSFERTS DE TECHNOLOGIES AVANCEES (FR) | 1993-04-15 | — | — | WO | claimed |
| EP-0112658-B1 | EXTRAOCULAR DEVICE FOR TREATING THE EYE | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1991-08-07 | — | — | EP | claimed |
| US-4775522-A | NMR compositions for indirectly detecting a dissolved gas in an animal | CHILDREN'S HOSPITAL RESEARCH FOUNDATION, A DIVISION OF CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1988-10-04 | — | — | US | claimed |
| EP-0274431-A2 | Drug delivery compositions and methods | QUIXOTE CORPORATION (US) | 1988-07-13 | — | — | EP | claimed |
| EP-0089815-B1 | LIQUID PERFLUOROCARBONS, FOR USE IN OCULAR THERAPY, AND PREPARATIONS CONTAINING THEM | Haidt, Sterling Joel (US) | 1986-12-17 | — | — | EP | claimed |
| EP-0138969-A1 | METHOD FOR INHIBITING THE GROWTH OF ANAEROBES | UNIVERSITY PATENTS, INC. (US) | 1985-05-02 | — | — | EP | claimed |
| WO-1984003624-A1 | METHOD FOR INHIBITING THE GROWTH OF ANAEROBES | UNIVERSITY PATENTS INC (US) | 1984-09-27 | — | — | WO | claimed |
| WO-2026106498-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-21 | — | — | WO | disclosed |
| EP-4731169-A1 | COMPOSITION WITH CHITOSAN AND A NATURAL RESIN | L'OREAL (FR) | 2026-04-29 | — | — | EP | disclosed |
| WO-1983002885-A1 | METHOD FOR PROVIDING AN OXYGEN BEARING LIQUID TO A BLOOD VESSEL FOR THE PERFORMANCE OF A MEDICAL PROCEDURE | LOEB, MARVIN, P. | 1983-09-01 | — | — | WO | disclosed |
| US-4289499-A | BY DETERMINATION OF CRITICAL SOLUTION TEMPERATURE | CHILDRENS HOSPITAL MEDICAL CENTER (US) | 1981-09-15 | — | — | US | disclosed |